The Natural Olive Constituent Oleuropein Induces Nutritional Cardioprotection in Normal and Cholesterol-Fed Rabbits: Comparison with Preconditioning

Abstract

Ischemic preconditioning, which is mediated by cell signaling molecules, protects the heart from ischemia-reperfusion injury by limiting the infarct size. Oleuropein, the main polyphenolic constituent of olives, reduced the infarct size in normal and cholesterol-fed rabbits when it was administered at a nutritional dose. The aim of the present study was to compare the effects of oleuropein and preconditioning in terms of the cell signaling and metabolism pathways underlying myocardial protection. Rabbits were randomly divided into six groups: the control group received 5 % dextrose for six weeks, the preconditioning group was subjected to two cycles of preconditioning with 5 min ischemia/10 min reperfusion, the O6 group was treated with oleuropein for six weeks, the Chol group was fed a cholesterol-enriched diet and 5 % dextrose for six weeks, and the CholO6 and CholO3 groups were treated with cholesterol and oleuropein for six and three weeks, respectively; oleuropein was dissolved in 5 % dextrose solution and was administered orally at a dose of 20 mg × kg⁻¹ × day⁻¹. All animals were subsequently subjected to 30 min myocardial ischemia followed by 10 min of reperfusion. At that time, myocardial biopsies were taken from the ischemic areas for the assessment of oxidative and nitrosative stress biomarkers (malondialdehyde and nitrotyrosine), and determination of phosphorylation of signaling molecules involved in the mechanism of preconditioning (PI3K, Akt, eNOS, AMPK, STAT3). The tissue extracts NMR metabolic profile was recorded and further analyzed by multivariate statistics. Oxidative biomarkers were significantly reduced in the O6, CholO6, and CholO3 groups compared to the control, preconditioning, and Chol groups. Considering the underlying signaling cascade, the phosphorylation of PI3K, Akt, eNOS, AMPK, and STAT-3 was significantly higher in the preconditioning and all oleuropein-treated groups compared to the control and Chol groups. The NMR-based metabonomic study, performed through the analysis of spectroscopic data, depicted differences in the metabolome of the various groups with significant alterations in purine metabolism. In conclusion, the addition of oleuropein to a normal or hypercholesterolemic diet results in a preconditioning-like intracellular effect, eliminating the deleterious consequences of ischemia and hypercholesterolemia, followed by a decrease of oxidative stress biomarkers. This effect is exerted through inducing preconditioning-involved signaling transduction. Nutritional preconditioning may support the low cardiovascular morbidity and mortality associated with the consumption of olive products.

Key words

Olea europaea - Oleaceae - oleuropein - preconditioning - oxidative stress - signaling molecules - metabonomics

• References

• 1 Omar SH. Oleuropein in olive and its pharmacological effects. Sci Pharm 2010; 78: 133-154
• 2 Masella R, Varì R, DʼArchivio M, Di Benedetto R. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr 2004; 134: 785-791
• 3 Andreadou I, Sigala F, Iliodromitis EK, Papaefthimiou M, Sigalas C, Aligiannis N, Savvari P, Gorgoulis V, Papalabros E, Kremastinos DT. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol 2007; 42: 549-558
• 4 Andreadou I, Papaefthimiou M, Zira A, Constantinou M, Sigala F, Skaltsounis AL, Tsantili-Kakoulidou A, Iliodromitis EK, Kremastinos DT, Mikros E. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein. NMR Biomed 2009; 22: 585-592
• 5 Andreadou I, Mikros E, Ioannidis K, Sigala F, Naka K, Kostidis S, Farmakis D, Tenta R, Kavantzas N, Bibli SI, Gikas E, Skaltsounis L, Kremastinos DTh, Iliodromitis EK. Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol 2014; 69: 4-16
• 6 DellʼAgli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Br J Nutr 2008; 99: 945-951
• 7 Manna C, Migliardi V, Golino P, Scognamiglio A, Galletti P, Chiariello M, Zappia V. Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion. J Nutr Biochem 2004; 15: 461-466
• 8 Andreadou I, Iliodromitis EK, Mikros E, Constantinou M, Agalias A, Magiatis P, Skaltsounis AL, Kamber E, Tsantili-Kakoulidou A, Kremastinos DT. The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 2006; 136: 2213-2219
• 9 Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Investig 2013; 123: 92-100
• 10 Parlakpinar H, Orum MH, Sagir M. Pathophysiology of myocardial ischemia reperfusion injury: a review. Med Sci 2013; 935-954
• 11 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136
• 12 Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction?. Eur Heart J 2012; 33: 13-15
• 13 Ardehali H. Signaling mechanisms in ischemic preconditioning: interaction of PKCε and mitoKATP in the inner membrane of mitochondria. Circulation Res 2006; 99: 798-800
• 14 Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009; 204: 334-341
• 15 Nishino Y, Miura T, Miki T, Sakamoto J, Nakamura Y, Ikeda Y, Kobayashi H, Shimamoto K. Ischemic preconditioning activates AMPK in a PKC- dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 2004; 61: 610-619
• 16 Young LH. AMP-activated protein kinase conducts the ischemic stress response orchestra. Circulation 2008; 117: 832-840
• 17 Abdukeyum G, Owen AJ, McLennan PL. Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J Nutr 2008; 138: 1902-1909
• 18 Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Nutr 1995; 61: 1360S-1367S
• 19 Widmer RJ, Freund MA, Flammer AJ, Sexton J, Lennon R, Romani A, Mulinacci N, Vinceri FF, Lerman LO, Lerman A. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur J Nutr 2013; 52: 1223-1231
• 20 Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997; 29: 207-216
• 21 Andreadou I, Iliodromitis EK, Souridis V, Prokovas E, Kostidis S, Zoga A, Dagres N, Tsantili-Kakoulidou A, Kremastinos DT, Mikros E, Anastasiou-Nana M. Investigating the effect of antioxidant treatment on the protective effect of preconditioning in anesthetized rabbits. J Cardiovasc Pharmacol 2011; 58: 609-616
• 22 Turan N, Csonska C, Csont T, Giricz Z, Fodor G, Bencsik P, Gyongyosi M, Cakici I, Ferdinandy P. The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. Cardiovasc Res 2006; 70: 384-390
• 23 Tsovolas K, Iliodromitis EK, Andreadou I, Zoga A, Demopoulou M, Iliodromitis K, Markantonis SL, Kremastinos DT. Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol Res 2008; 57: 283-289
• 24 Speroni E, Guerra MC, Minghetti A, Crespi-Perellino N, Pasini P, Piazza F. Oleuropein evaluated in vitro and in vivo as an antioxidant. Phytother Res 1998; 12: 98-100
• 25 Schulz R, Cohen V M, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res 2001; 52: 181-198
• 26 Oldenburg O, Qin Q, Krieg T, Yang XM, Philipp S, Critz SD, Cohen MV, Downey JM. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 2004; 286: H468-H476
• 27 Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004; 61: 448-460
• 28 Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 2004; 288: H971-H976
• 29 Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, Bolli R. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 2000; 279: H2360-H2371
• 30 Nandagopal K, Dawson TM, Dawson VL. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. JPET 2001; 297: 474-478
• 31 Smith RM, Suleman N, Lacerda L, Opie LH, Akira S, Chien KR, Sack MN. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res 2004; 63: 611-616
• 32 Cserepes B, Jancsó G, Gasz B, Rácz B, Ferenc A, Benkó L, Borsiczky B, Kürthy M, Ferencz S, Lantos J, Gál J, Arató E, Miseta A, Wéber G, Róth E. Cardioprotective action of urocortin in early pre- and postconditioning. Ann N Y Acad Sci 2007; 1095: 228-239
• 33 Bergeron R, Russell RR, Young LH, Ren JM, Marcucci M, Lee A, Shulman GI. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 1999; 276: E938-E944
• 34 Calvert JW, Gundewr JW, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 2008; 57: 696-705
• 35 Lopaschuk GD. AMP-activated protein kinase control of energy metabolism in the ischemic heart. Int J Obes 2008; 32: S29-S35
• 36 Paiva MA, Gonçalves LM, Providência LA, Davidson SM, Yellon DM, Mocanu MM. Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther 2010; 24: 25-32
• 37 Stein LR, Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab 2012; 23: 420-428
• 38 Imai S. Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett 2011; 585: 1657-1662
• 39 Hsu CP, Oka S, Shao D, Hariharan N, Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 2009; 105: 481-491
• 40 Yamamoto T, Byun J, Zhai P, Ikeda Y, Oka S, Sadoshima J. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS ONE 2014; 9: e98972
• 41 Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008; 14: 661-673
• 42 Morrison A, Li J. PPAR-c and AMPK-advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol 2011; 82: 195-200
• 43 Monassier JP. Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations. Arch Card Dis 2008; 101: 491-500
• 44 Angelos MG, Griffith RF, Beckley PD, Rath DP, Little CM. Myocardial metabolic changes during reperfusion of ventricular fibrillation: a ³¹P nuclear magnetic resonance study in swine. Crit Care Med 1995; 23: 733-739
• 45 Dyballa-Rukes N, Schuh C, Vogt H, Toma O, Schlack WS, Weber NC, Metzger S. In vivo desflurane preconditioning evokes dynamic alterations of metabolic proteins in the heart – proteomic insights strengthen the link between bioenergetics and cardioprotection. Cell Physiol Biochem 2014; 33: 967-981
• 46 Orbetzova V, Kiprov D. Effect of cholesterol-rich diet on the content of nicotinamide nucleotides, adenine nucleotides and acetyl-CoA in the liver, the vascular wall and the kidney of spontaneously hypertensive rats [SHR]. Cor Vasa 1979; 21: 353-362
• 47 Hardie DG. The AMP-activated protein kinase pathway – new players upstream and downstream. J Cell Sci 2004; 117: 5479-5487
• 48 Svobodova M, Andreadou I, Skaltsounis AL, Kopecky J, Flachs P. Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma. Genes & Nutrition 2014; 9: 376
• 49 Quaranta G, Rotundo V. Economic and commercial prospects for olive oil in view of the changes in the common market organisation (CMO) (Part one). Olivae 2000; 91: 20-24
• 50 Andreadou I, Farmakis D, Prokovas Ε, Sigala F, Zoga Α, Spyridaki K, Papalois A, Papapetropoulos A, Anastasiou-Nana Μ, Kremastinos DT, Iliodromitis ΕΚ. Short-term statin administration in hypercholesterolemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase and nitro-oxidative stress. Cardiovasc Res 2012; 94: 501-509
• 51 Andreadou I, Iliodromitis EK, Tsovolas K, Aggeli IK, Zoga A, Gaitanaki C, Markantonis S, Beis I, Kremastinos DT. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med 2006; 41: 1092-1099
• 52 Bibli SI, Andreadou I, Lazaris E, Zoga A, Varnavas V, Andreou CC, Dagres N, Iliodromitis EK, Kyriakides ZS. Myocardial protection provided by chronic skeletal muscle ischemia is not further enhanced by ischemic pre- or post-conditioning: comparative effects on intracellular signalling. J Cardiovasc Pharmacol Ther 2014; 19: 220-227
• 53 Senn H, Schlotterbeck G. NMR spectroscopy techniques for application to metabonomics. In: Lindon JC, Nicholson JK, Holmes E, editors The handbook of metabonomics and metabolomics. Amsterdam: Elsevier; 2007: 55-112
• 54 Pechlivanis A, Kostidis S, Saraslanidis P, Petridou A, Tsalis G, Mougios V, Gika HG, Mikros E, Theodoridis GA. ¹H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. J Proteome Res 2010; 9: 6405-6416
• 55 Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dillution of complex biological mixtures. Application to ¹H NMR metabolomics. Anal Chem 2006; 78: 4281-4290
• 56 Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 2011; 6: 743-760